LGVN Class A Longeveron Inc. - Class A Common stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 12, 2026
$2.58
· of 52w range
· above low
· to high
$2.3052w low
$12.3052w high
P/E (TTM)
-2.6
EPS (TTM)
$-1.00
Revenue (TTM)
$1M
your badges
52W Range
$2–$12
Analyst Rating
BUY
Price Target
$61
P/E
-2.6
ROE
-203.6%
Net Profit Margin
-1977.6%
Your badge strip is empty — pin a metric anywhere on this page.
LGVN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.58
P/E (TTM)
-2.6
EPS (TTM)
$-1.00
Revenue (TTM)
$1M
ROE (TTM)
-203.6%
52W Range
$2–$12
LGVN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Aug. 27, 2026 | 1-for-10 | Reverse |
| March 27, 2024 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$1M2020-12-31 → 2025-12-31
EPS$-1.292021-12-31 → 2025-12-31
Free Cash Flow$-19M2021-12-31 → 2025-12-31
Net margin-1977.6%2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | LGVN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -2.65Y avg ≈-34.5 | ≈-34.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | LGVN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 69.8%5Y avg ≈57.9% | ≈57.9% | · | · | |
| Operating Margin (TTM) | -1992.8%5Y avg ≈-1361.5% | ≈-1361.5% | -2298.3% | In line | |
| EBITDA Margin (TTM) | -1925.4%5Y avg ≈-1337.5% | ≈-1337.5% | -2260.7% | In line | |
| Net Profit Margin (TTM) | -1977.6%5Y avg ≈-1352.0% | ≈-1352.0% | -2028.1% | Weak | |
| ROA (TTM) | -145.6%5Y avg ≈-82.7% | ≈-82.7% | -124.3% | In line | |
| ROE (TTM) | -203.6%5Y avg ≈-113.9% | ≈-113.9% | -270.9% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | LGVN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 2.65Y avg ≈6.5 | ≈6.5 | 1.8 | Strong liquidity | |
| Quick Ratio | 1.25Y avg ≈6.0 | ≈6.0 | 1.6 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | LGVN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -49.9%5Y avg ≈12.5% | ≈12.5% | · | · | |
| Revenue CAGR 3Y | -0.63%5Y avg ≈-9.4% | ≈-9.4% | · | · | |
| Revenue CAGR 5Y | -26.6% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | LGVN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.15Y avg ≈0.1 | ≈0.1 | 0.0 | Top tier | |
| Receivables Turnover | 12.85Y avg ≈15.4 | ≈15.4 | · | · | |
| Revenue / Employee | ≈$31.6K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-5.9%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-1.90 | $-1.78 | -6.4% |
| March 31, 2026 | May 13, 2026 | $-1.90 | $-1.68 | -12.9% |
| Dec. 31, 2025 | $-2.30 | $-4.23 | 45.7% | |
| Sept. 30, 2025 | $-3.90 | $-2.60 | -49.9% | |
| June 30, 2025 | $-0.33 | $-0.36 | 8.2% | |
| March 31, 2025 | $-0.34 | $-0.33 | -1.8% | |
| Dec. 31, 2024 | $-0.43 | $-0.35 | -24.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $709.0K | $1M | $1M | $6M | |
| Cost of Revenue | $396.0K | $508.0K | $488.0K | $725.0K | $716.0K | $4M | |
| Gross Profit | $803.0K | $2M | $221.0K | $497.0K | $590.0K | $2M | |
| R&D Expense | $12M | $8M | $9M | $9M | $7M | $3M | |
| SG&A Expense | $12M | $10M | $12M | $8M | $10M | $3M | |
| Operating Expenses | $24M | $18M | $21M | $19M | $18M | $6M | |
| Operating Income | $-23M | $-17M | $-21M | $-18M | $-17M | $-4M | |
| Interest Expense | · | · | · | $1M | · | · | |
| Other Non-op | $680.0K | $549.0K | $-377.0K | $300.0K | $411.0K | $57.0K | |
| Income Tax | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-23M | $-16M | $-21M | $-19M | $-17M | $-4M | |
| EPS (Basic) | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 | · | |
| EPS (Diluted) | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 | · | |
| Shares (Basic) | 17,576,551,000 | 9,411,164,000 | 2,173,490,000 | 20,969,032 | 18,915,086 | · | |
| Shares (Diluted) | 17,576,551,000 | 9,411,164,000 | 2,173,490,000 | 20,969,032 | 18,915,086 | · | |
| EBITDA | $-22M | $-16M | · | $-18M | $-17M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $19M | $5M | $11M | $26M | $816.0K | |
| Short-term Investments | · | $0 | $412.0K | $9M | $9M | · | |
| Receivables | $104.0K | $84.0K | $111.0K | $218.0K | $55.0K | · | |
| Prepaid Expense | $686.0K | $308.0K | $376.0K | $404.0K | $282.0K | $52.0K | |
| Current Assets | $5M | $20M | $6M | $20M | $35M | $2M | |
| PP&E (Net) | $2M | $2M | $3M | $3M | $3M | $4M | |
| PP&E (Gross) | $8M | $8M | $7M | $7M | $6M | $6M | |
| Accum. Depreciation | $6M | · | · | · | $3M | $3M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $176.0K | $202.0K | $193.0K | $244.0K | · | · | |
| Total Assets | $10M | $26M | $12M | $27M | $43M | $9M | |
| Accounts Payable | $423.0K | $99.0K | $638.0K | $2M | $645.0K | $2M | |
| Accrued Liabilities | $3M | $2M | $2M | $650.0K | $1M | $2M | |
| Current Liabilities | $4M | $3M | $4M | $5M | $3M | $4M | |
| Capital Leases | $169.0K | $824.0K | $1M | $2M | · | · | |
| Other Non-current Liabilities | $330.0K | $265.0K | $0 | · | · | · | |
| Total Liabilities | $5M | $4M | $5M | $7M | $5M | $7M | |
| Long-term Debt | · | · | · | · | · | $311.0K | |
| Common Stock | · | · | · | $6.0K | $5.0K | · | |
| Paid-in Capital | $138M | $131M | $92M | $84M | $81M | · | |
| Retained Earnings | $-132M | $-110M | $-85M | $-63M | $-44M | · | |
| Treasury Stock | · | · | · | $100.0K | $100.0K | · | |
| AOCI | · | · | $0 | $-357.0K | · | · | |
| Stockholders' Equity | $6M | $22M | $7M | $21M | $37M | $2M | |
| Liabilities + Equity | $10M | $26M | $12M | $27M | $43M | $9M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $800.0K | $700.0K | $700.0K | $700.0K | $1 | $1 | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $1M | $44.0K | |
| Amort. of Intangibles | $400.0K | $200.0K | $200.0K | $200.0K | $200.0K | $100.0K | |
| Other Non-cash | $2M | $-923.0K | · | $5M | $6M | · | |
| Operating Cash Flow | $-19M | $-14M | $-19M | $-14M | $-10M | $-2M | |
| CapEx | $245.0K | $655.0K | $301.0K | $569.0K | $330.0K | $131.0K | |
| Investing Cash Flow | $-595.0K | $-640.0K | $8M | $-677.0K | $-11M | $-261.0K | |
| Stock Issued | $5M | $13M | $5M | $2.0K | $27M | · | |
| Net Stock Activity | $5M | $13M | · | · | $27M | · | |
| Financing Cash Flow | $5M | $29M | $5M | $-509.0K | $45M | $2M | |
| Taxes Paid | $0 | · | · | · | · | · | |
| Free Cash Flow | $-19M | $-15M | · | $-15M | $-10M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 67.0% | 78.8% | · | 40.7% | 45.2% | · | |
| Operating Margin | -1942.2% | -690.7% | · | -1476.5% | -1336.6% | · | |
| Net Margin | -1893.6% | -667.8% | · | -1541.3% | -1305.1% | · | |
| EBITDA Margin | -1875.5% | -661.4% | · | -1476.5% | -1336.6% | · | |
| ROA | -126.8% | -84.9% | · | -53.7% | -65.5% | · | |
| ROE | -247.7% | -67.2% | · | -83.5% | -57.0% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 7.6 | · | 4.2 | 13.1 | · | |
| Quick Ratio | 1.2 | 7.5 | · | 2.2 | 13.0 | · | |
| Interest Coverage | · | · | · | -12.9 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.0 | 0.1 | · | |
| Receivables Turnover | 12.8 | 24.5 | · | 9.0 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.00 | $0.00 | · | $0.06 | · | · | |
| Cash Flow / Share | $-0.00 | $-0.00 | · | $-0.67 | · | · | |
| EPS (TTM) | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -49.9% | 237.4% | -42.0% | -6.4% | -76.8% | · | |
| Revenue CAGR 3Y | -0.63% | 22.4% | -49.9% | · | · | · | |
| Revenue CAGR 5Y | -26.6% | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $2M | $709.0K | $1M | $1M | $6M | |
| Net Income TTM | $-23M | $-16M | $-21M | $-19M | $-17M | $-4M | |
| P/E | -0.4 | -0.7 | -1.3 | -35.8 | -134.1 | · | |
| Earnings Yield | -254.9% | -151.4% | -75.1% | -2.8% | -0.75% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $287.0K | $398.0K | $365.0K | $137.0K | $316.0K | $381.0K | $603.0K | $773.0K | $468.0K | $548.0K | $63.0K | $150.0K | $217.0K | $279.0K | $121.0K | $265.0K | |
| Cost of Revenue | $105.0K | $134.0K | $108.0K | $12.0K | $170.0K | $106.0K | $74.0K | $91.0K | $124.0K | $219.0K | $65.0K | $96.0K | $124.0K | $203.0K | $41.0K | $173.0K | |
| Gross Profit | $182.0K | $264.0K | $257.0K | $125.0K | $146.0K | $275.0K | $529.0K | $682.0K | $344.0K | $329.0K | $-2.0K | $54.0K | $93.0K | $76.0K | $80.0K | $92.0K | |
| R&D Expense | $3M | $2M | $3M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| SG&A Expense | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $2M | $2M | $2M | |
| Operating Expenses | $6M | $5M | $6M | $7M | $6M | $5M | $5M | $5M | $4M | $4M | $5M | $5M | $6M | $5M | $5M | $5M | |
| Operating Income | $-6M | $-5M | $-5M | $-7M | $-5M | $-5M | $-4M | $-5M | $-4M | $-4M | $-5M | $-5M | $-6M | $-5M | $-5M | $-5M | |
| Other Non-op | $98.0K | $39.0K | $52.0K | $89.0K | $369.0K | $170.0K | $200.0K | $230.0K | $87.0K | $32.0K | $-581.0K | $55.0K | $80.0K | $69.0K | $2M | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-6M | $-5M | $-5M | $-7M | $-5M | $-5M | $-4M | $-4M | $-3M | $-4M | $-6M | $-5M | $-6M | $-5M | $-4M | $-5M | |
| EPS (Basic) | $-0.19 | $-0.19 | $-0.23 | $-0.39 | $-0.33 | $-0.34 | $1.16 | $-0.34 | $-1.83 | $-1.61 | $-2.55 | $-2.79 | $-2.67 | $-2.21 | $-0.21 | $-0.25 | |
| EPS (Diluted) | $-0.19 | $-0.19 | $-0.23 | $-0.39 | $-0.33 | $-0.34 | $1.16 | $-0.34 | $-1.83 | $-1.61 | $-2.55 | $-2.79 | $-2.67 | $-2.21 | $-0.21 | $-0.25 | |
| Shares (Basic) | 31,377,630 | 24,786,282,000 | · | 18,373,198,000 | 15,013,072 | 14,950,734,000 | · | 13,627,793,000 | 6,509,881,000 | 2,513,587,000 | · | 2,117,877,000 | 2,110,544 | 2,103,362 | · | 21,001,613 | |
| Shares (Diluted) | 31,377,630 | 24,786,282,000 | · | 18,373,198,000 | 15,013,072 | 14,950,734,000 | · | 13,627,793,000 | 6,509,881,000 | 2,513,587,000 | · | 2,117,877,000 | 2,110,544 | 2,103,362 | · | 21,001,613 | |
| EBITDA | $-6M | $-5M | · | $-7M | $-5M | $-5M | · | $-5M | $-3M | $-4M | · | $-5M | $-6M | $-5M | · | $-5M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $16M | $5M | $9M | $10M | $14M | $19M | $23M | $12M | $2M | $5M | $2M | $3M | $5M | $11M | $14M | |
| Short-term Investments | · | · | · | · | · | $0 | · | $0 | · | $351.0K | $412.0K | $2M | · | · | $9M | $9M | |
| Receivables | $65.0K | $68.0K | $104.0K | $52.0K | $31.0K | $29.0K | $84.0K | $380.0K | $218.0K | $178.0K | $111.0K | $96.0K | $96.0K | $96.0K | $218.0K | · | |
| Prepaid Expense | $1M | $1M | $686.0K | $1M | $904.0K | $919.0K | $308.0K | $609.0K | $817.0K | $1M | $376.0K | $1M | $2M | $1M | $404.0K | $744.0K | |
| Current Assets | $11M | $17M | $5M | $10M | $11M | $15M | $20M | $24M | $13M | $4M | $6M | $5M | $10M | $15M | $20M | $23M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | $6M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $12.0K | $18.0K | $176.0K | $178.0K | $200.0K | $201.0K | $202.0K | $203.0K | $204.0K | $190.0K | $193.0K | · | · | · | $244.0K | · | |
| Total Assets | $15M | $21M | $10M | $16M | $17M | $21M | $26M | $30M | $19M | $10M | $12M | $12M | $17M | $22M | $27M | $31M | |
| Accounts Payable | $633.0K | $293.0K | $423.0K | $1M | $700.0K | $367.0K | $99.0K | $887.0K | $600.0K | $1M | $638.0K | $829.0K | $2M | · | $2M | $527.0K | |
| Accrued Liabilities | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $613.0K | $650.0K | $728.0K | |
| Current Liabilities | $4M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | $3M | $5M | $4M | $3M | $4M | $4M | $5M | $4M | |
| Capital Leases | $0 | $60.0K | $169.0K | $336.0K | $501.0K | $664.0K | $824.0K | $983.0K | $1M | $1M | $1M | $2M | $2M | · | $2M | · | |
| Other Non-current Liabilities | $0 | $0 | $330.0K | $315.0K | $308.0K | $302.0K | $265.0K | $199.0K | $132.0K | $66.0K | $0 | · | · | · | · | · | |
| Total Liabilities | $5M | $5M | $5M | $6M | $4M | $4M | $4M | $4M | $4M | $7M | $5M | $5M | $6M | $5M | $7M | $6M | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | · | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $153M | $153M | $138M | $137M | $132M | $132M | $131M | $131M | $116M | $92M | $92M | $86M | $85M | $84M | $84M | $83M | |
| Retained Earnings | $-143M | $-137M | $-132M | $-127M | $-120M | $-115M | $-110M | $-106M | $-101M | $-89M | $-85M | $-79M | $-73M | $-67M | $-63M | $-58M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| AOCI | · | · | · | · | · | · | · | $-1.0K | $-1.0K | $1.0K | · | $-309.0K | $-335.0K | $-299.0K | $-357.0K | · | |
| Stockholders' Equity | $10M | $16M | $6M | $10M | $13M | $17M | $22M | $26M | $15M | $3M | $7M | $7M | $11M | $16M | $21M | $25M | |
| Liabilities + Equity | $15M | $21M | $10M | $16M | $17M | $21M | $26M | $30M | $19M | $10M | $12M | $12M | $17M | $22M | $27M | $31M |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $100.0K | $200.0K | $200.0K | $200.0K | $100.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | |
| Stock-based Comp | $373.0K | $379.0K | $376.0K | $448.0K | $513.0K | $340.0K | $390.0K | $1M | $230.0K | $295.0K | $413.0K | $499.0K | $699.0K | $421.0K | $476.0K | · | |
| Amort. of Intangibles | $0 | $100.0K | $0 | $100.0K | $100.0K | $200.0K | $-300.0K | $100.0K | $300.0K | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K | |
| Other Non-cash | · | $-213.0K | · | · | · | $-226.0K | · | · | · | $477.0K | · | · | · | $-1M | · | · | |
| Operating Cash Flow | $-6M | $-4M | $-5M | $-5M | $-4M | $-5M | $-3M | $-3M | $-5M | $-3M | $-4M | $-5M | $-5M | $-6M | $-2M | $-4M | |
| CapEx | $103.0K | $0 | $0 | $57.0K | $161.0K | $27.0K | $13.0K | $430.0K | $196.0K | $16.0K | $164.0K | $3.0K | $92.0K | $42.0K | $66.0K | $378.0K | |
| Investing Cash Flow | $-103.0K | $-20.0K | $-64.0K | $-118.0K | $-263.0K | $-150.0K | $-123.0K | $-478.0K | $-53.0K | $14.0K | $2M | $4M | $2M | $346.0K | $-570.0K | $-2M | |
| Stock Issued | · | · | $836.0K | · | · | · | $0 | $8M | $5M | $100.0K | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $100.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $75.0K | $15M | $777.0K | $4M | $-133.0K | $-58.0K | $-50.0K | $14M | $15M | $63.0K | $5M | $-50.0K | $-86.0K | $-17.0K | $-193.0K | $-27.0K | |
| Free Cash Flow | · | $-4M | · | · | · | $-5M | · | · | · | $-3M | · | · | · | $-6M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 66.3% | · | 91.2% | 46.2% | 72.2% | · | 88.2% | 73.5% | 60.0% | · | 36.0% | 42.9% | 27.2% | · | 34.7% | |
| Operating Margin | -2150.2% | -1199.8% | · | -5335.8% | -1707.9% | -1359.8% | · | -601.4% | -747.9% | -746.4% | · | -3440.7% | -2632.3% | -1690.3% | · | -1957.4% | |
| Net Margin | -2116.0% | -1190.0% | · | -5270.8% | -1591.1% | -1315.2% | · | -571.7% | -729.3% | -740.5% | · | -3404.0% | -2595.4% | -1665.6% | · | -1978.9% | |
| EBITDA Margin | -2080.5% | -1149.5% | · | -5189.8% | -1644.6% | -1307.3% | · | -601.4% | -705.1% | -709.8% | · | -3307.3% | -2540.1% | -1618.6% | · | -1881.9% | |
| ROA | -37.7% | -22.5% | · | -31.8% | -27.8% | -32.8% | · | -21.3% | -18.7% | -25.8% | · | -24.2% | -21.5% | -15.2% | · | -18.2% | |
| ROE | -52.7% | -28.5% | · | -40.6% | -36.5% | -49.6% | · | -27.4% | -26.1% | -41.9% | · | -32.7% | -27.7% | -18.4% | · | -22.3% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 3.9 | · | 2.1 | 3.4 | 5.6 | · | 7.7 | 4.2 | 0.7 | · | 1.5 | 2.5 | 4.1 | · | 6.3 | |
| Quick Ratio | 2.4 | 3.6 | · | 1.9 | 3.2 | 5.3 | · | 7.5 | 3.9 | 0.5 | · | 1.2 | 0.7 | 1.4 | · | 6.0 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 6.0 | 8.2 | · | 0.6 | 2.5 | 3.7 | · | 3.2 | 3.0 | 4.0 | · | 3.1 | 4.5 | 5.8 | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.01 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.07 | $0.22 | · | $0.01 | $0.01 | $0.01 | · | $0.01 | |
| Cash Flow / Share | · | $-0.00 | · | · | · | $-0.00 | · | · | · | $-1.23 | · | · | · | $-0.28 | · | · | |
| EPS (TTM) | $-1.00 | $-1.14 | · | $0.10 | $0.15 | $-1.35 | · | $-6.33 | $-8.78 | $-9.62 | · | $-7.88 | $-5.34 | $-2.94 | · | $-0.89 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $1M | $2M | $2M | · | $2M | $1M | $978.0K | · | $767.0K | $882.0K | $1M | · | $1M | |
| Net Income TTM | $-23M | $-22M | · | $-21M | $-19M | $-17M | · | $-18M | $-19M | $-21M | · | $-20M | $-20M | $-20M | · | $-18M | |
| P/E | -0.7 | -0.9 | · | 7.5 | 8.7 | -1.1 | · | -0.3 | -0.2 | -0.3 | · | -3.0 | -6.3 | -9.1 | · | -41.6 | |
| Earnings Yield | -142.2% | -109.6% | · | 13.3% | 11.5% | -87.1% | · | -326.3% | -545.3% | -296.0% | · | -33.7% | -15.8% | -11.0% | · | -2.4% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $1M | $2M | $709.0K | $1M | $1M |
| Gross Margin % | 67.0% | 78.8% | · | 40.7% | 45.2% |
| Operating Margin % | -1942.2% | -690.7% | · | -1476.5% | -1336.6% |
| Net Income | $-23M | $-16M | $-21M | $-19M | $-17M |
| Diluted EPS | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.3 | 7.6 | · | 4.2 | 13.1 |
| Quick Ratio | 1.2 | 7.5 | · | 2.2 | 13.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-19M | $-15M | · | $-15M | $-10M |
Institutional owners (13F) 41 filers · $3.6M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
41
Value held
$3.6M
New positions
13
Exited positions
5
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 13 (+2 vs prior Q) | 5 (-4 vs prior Q) | 7 (+4 vs prior Q) | 3 (0 vs prior Q) | +2.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | $951,778 | 1,353,881 | 26.74% | Shares |
| Logos Global Management LP | $904,761 | 1,287,000 | 25.42% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $408,657 | 581,305 | 11.48% | Shares |
| VANGUARD GROUP INC | $252,558 | 499,126 | 7.10% | Shares |
| BlackRock, Inc. | $157,592 | 224,170 | 4.43% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $143,244 | 203,761 | 4.03% | Shares |
| JANE STREET GROUP, LLC | $133,831 | 190,370 | 3.76% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $98,509 | 140,127 | 2.77% | Shares |
| Mariner, LLC | $88,578 | 126,000 | 2.49% | Shares |
| ADAR1 Capital Management, LLC | $76,209 | 108,406 | 2.14% | Shares |
| Beacon Pointe Advisors, LLC | $70,300 | 100,000 | 1.98% | Shares |
| TWO SIGMA SECURITIES, LLC | $39,349 | 55,973 | 1.11% | Shares |
| STATE STREET CORP | $31,902 | 45,380 | 0.90% | Shares |
| NORTHERN TRUST CORP | $30,439 | 43,299 | 0.86% | Shares |
| SCOTIA CAPITAL INC. | $21,090 | 30,000 | 0.59% | Shares |
| Capital Investment Advisory Services, LLC | $18,647 | 26,525 | 0.52% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $17,680 | 25,155 | 0.50% | Shares |
| Hamilton Point Investment Advisors, LLC | $15,780 | 22,446 | 0.44% | Shares |
| MONETA GROUP INVESTMENT ADVISORS LLC | $14,974 | 21,300 | 0.42% | Shares |
| XTX Topco Ltd | $14,452 | 20,558 | 0.41% | Shares |
| ANCHYRA PARTNERS LLC | $14,060 | 20,000 | 0.40% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $13,938 | 19,827 | 0.39% | Shares |
| Accelerate Investment Advisors LLC | $10,018 | 14,250 | 0.28% | Shares |
| Valeo Financial Advisors, LLC | $7,640 | 10,867 | 0.21% | Shares |
| Cambridge Financial Group, LLC | $7,382 | 10,500 | 0.21% | Shares |
| Tower Research Capital LLC (TRC) | $5,922 | 8,424 | 0.17% | Shares |
| MCGUIRE CAPITAL ADVISORS INC | $2,812 | 4,000 | 0.08% | Shares |
| Steward Partners Investment Advisory, LLC | $1,673 | 2,380 | 0.05% | Shares |
| OSAIC HOLDINGS, INC. | $1,400 | 2,000 | 0.04% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $930 | 1,300 | 0.03% | Shares |
| Cornerstone Planning Group LLC | $705 | 1,125 | 0.02% | Shares |
| WELLS FARGO & COMPANY/MN | $703 | 1,000 | 0.02% | Shares |
| BARCLAYS PLC | $587 | 835 | 0.02% | Shares |
| MORGAN STANLEY | $478 | 680 | 0.01% | Shares |
| Allworth Financial LP | $92 | 130 | 0.00% | Shares |
| Aventura Private Wealth, LLC | $55 | 78 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $42 | 60 | 0.00% | Shares |
| Virtu Financial LLC | $41 | 58,583 | 0.00% | Shares |
| UBS Group AG | $4 | 5 | 0.00% | Shares |
| CWM, LLC | $3 | 3 | 0.00% | Shares |
| HUNTINGTON NATIONAL BANK | $2 | 1 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Joshua M. Hare, M.D. (2) ×4 filings | April 15, 2024 | · | Initial filing | · | SEC |
| DS MED LLC (2), Donald M. Soffer (2) ×2 filings | May 25, 2022 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 30 insiders · 12 officers · 18 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Stephen H Willard | Chief Executive Officer | July 1, 2026 F | 771,681 | 0 | 0 | $0 |
| James Nathaniel Powell | Chief Executive Officer | Jan. 2, 2026 F | 125,593 | 0 | 0 | $0 |
| Mohamed Wa'El Ahmed Hashad | Chief Executive Officer | July 15, 2025 A | 420,904 | 0 | 0 | $0 |
| Geoff Green | CEO | April 4, 2022 F | 133,904 | 0 | 0 | $0 |
| Nirav S. Jhaveri | Chief Financial Officer | Aug. 17, 2026 A | 300,000 | 0 | 0 | $0 |
| Lisa Locklear | Chief Financial Officer | July 1, 2026 F | 443,181 | 0 | 0 | $0 |
| James Clavijo | CFO and Treasurer | June 29, 2023 S | 47,303 | 0 | 0 | $0 |
| Devin Blass | CTO & SVP of CMC | Aug. 19, 2026 A | 711,735 | 0 | 0 | $0 |
| Nataliya Agafonova | Chief Medical Officer | Aug. 19, 2026 A | 716,914 | 0 | 0 | $0 |
| Paul T Lehr | General Counsel, Secretary | Aug. 19, 2026 A | 861,423 | 0 | 0 | $0 |
| Joshua Hare | Chief Scientific Officer | Aug. 19, 2026 A | 1,607,796 | 0 | 0 | $0 |
| Kwan-Hong Christopher Min | Chief Medical Officer | April 4, 2022 A | 151,978 | 0 | 0 | $0 |
| George A. Paletta Jr. | Director | Aug. 19, 2026 A | 70,000 | 0 | 0 | $0 |
| Roger Joseph Hajjar | Director | Aug. 19, 2026 A | 69,000 | 0 | 0 | $0 |
| Arjun Jj Desai | Director | Aug. 19, 2026 A | 36,000 | 0 | 0 | $0 |
| Ursula Ungaro | Director | Aug. 19, 2026 A | 77,000 | 0 | 0 | $0 |
| Rock Soffer | Director | Aug. 19, 2026 A | 262,034 | 0 | 0 | $0 |
| Deborah Ascheim | Director | Aug. 19, 2026 A | 36,000 | 0 | 0 | $0 |
| Leah Rush Cann | Director | Aug. 19, 2026 A | 36,000 | 0 | 0 | $0 |
| Khoso Baluch | Director | Aug. 11, 2025 P | 52,516 | 0 | 0 | $0 |
| Neha J. Motwani | Director | July 15, 2025 A | 33,000 | 0 | 0 | $0 |
| Richard N Kender | Director | July 15, 2025 A | 33,000 | 0 | 0 | $0 |
| Neil E Hare | Director | Aug. 15, 2024 A | 29,352 | 0 | 0 | $0 |
| Cathy Ross | Director | Jan. 10, 2024 P | 10,000 | 0 | 0 | $0 |
| Jeffrey Pfeffer | Director | Dec. 28, 2023 P | 15,000 | 0 | 0 | $0 |
| Douglas W Losordo | Director | Dec. 21, 2023 A | 5,000 | 0 | 0 | $0 |
| Todd C Girolamo | Director | Dec. 21, 2022 A | 5,000 | 0 | 0 | $0 |
| Donald M Soffer | Director | Dec. 21, 2022 A | 6,693,737 | 0 | 0 | $0 |
| Erin Borger | Director | Dec. 21, 2022 A | 0 | 0 | 0 | $0 |
| DS MED LLC | 10% owner | May 17, 2022 J | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
LGVN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$61.25
+2274.0%
2 22.2%
Strong Buy
5 55.6%
Buy
2 22.2%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-10-03Mean target $61.25 +2274.0%
← Below all targets
Current price $2.58
Low$42.50
Mean$61.25
High$80.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 12, 2026